Clinical Trials on Chronic Paraplegia

Total 32368 results

Suzhou Ribo Life Science Co. Ltd.

Recruiting

A Study of RBD1016 in CHB Participants

Chronic Hepatitis b

Sweden
Associazione Italiana Pazienti Leucemia Mieloide...

Not yet recruiting

Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia (CarPAs)

Chronic Myeloid Leukemia (CML)

Italy
Young-Suk Lim
Samsung Medical Center; Seoul St. Mary's Hospital; China Medical University Hospital and other collaborators

Recruiting

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines (ATTENTION)

Chronic Hepatitis b

Korea, Republic of
University Hospital, Clermont-Ferrand
Centre Leon Berard; Versailles Hospital; University Hospital, Grenoble; Institut... and other collaborators

Recruiting

EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors (EPIK)

Chronic Myeloid Leukemia (CML) | Chronic Phase

France
Temple University
National Center for Complementary and Integrative Health (NCCIH); Quercegen...

Recruiting

Biological Effects of Quercetin in COPD Phase II (polyphenols)

Chronic Obstructive Pulmonary Disease | Emphysema | Chronic Bronchitis With Airway Obstruction

United States
Ascletis Pharmaceuticals Co., Ltd.
Peking University First Hospital; Beijing Clinical Service Center

Active, not recruiting

A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients

Chronic Hepatitis b

China
Suzhou Ribo Life Science Co. Ltd.

Completed

A Single and Repeated Dose Escalation of RBD1016 in Subjects With Chronic Hepatitis B Virus (HBV) Infection

Chronic Hepatitis b

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Completed

Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasms | Atypical Chronic Myeloid Leukemia | Myelodysplastic/Myeloproliferative Overlapping Syndrome

United States
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

Chronic Kidney Disease Requiring Chronic Dialysis

United States
University of Cologne

Completed

Effect of a Pre-interventional Diet on Renal Function After Administration of Contrast Agent in Patients at Risk (CR_KMN)

Renal Failure Chronic Contrast Induced

Germany
Hospices Civils de Lyon

Completed

Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure (COREV)

Chronic Renal Insufficiency | Cardiac Transplantation

France
Baxter Healthcare Corporation
University of Louisville; Gambro Renal Products, Inc.

Completed

A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis

Renal Failure Chronic Requiring Hemodialysis

United States
Kantonsspital Aarau
Fresenius Medical Care Deutschland GmbH

Completed

Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser

Renal Failure Chronic Requiring Hemodialysis

Switzerland
Sin-Lau Hospital

Unknown

Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients

Renal Failure Chronic Requiring Hemodialysis

Taiwan
Aveiro University

Active, not recruiting

A Pilot Study of a Neural Mobilization Intervention Applied to Older Adults With Chronic Musculoskeletal Pain

Chronic Pain | Older Adults | Chronic Musculoskeletal Pain | Chronic Musculoskeletal Disease

Portugal
University Hospital, Limoges

Terminated

Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients. (DIAMS)

Renal Failure Chronic Requiring Hemodialysis

France
Fundación Senefro

Unknown

Study to Explore Morbimortality in Patients Dialyzed With the Theranova HDx in Comparison to On-Line-Hemodiafiltration

Chronic Kidney Disease Requiring Chronic Dialysis

Spain
Baxter Healthcare Corporation
University of California, Davis; Vanderbilt University Medical Center; University... and other collaborators

Completed

Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate

Chronic Kidney Disease | Chronic Renal Disease

United States
Hospital Universitario Infanta Leonor

Completed

Cellulose Triacetate Dialyzer in Hemodiafiltration-online

Chronic Kidney Disease Requiring Chronic Dialysis

Spain
National Taiwan University Hospital
Mackay Memorial Hospital; Shin Kong Wu Ho-Su Memorial Hospital; Taipei Medical... and other collaborators

Unknown

Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) (CKD)

Chronic Renal Failure

Taiwan
Rush University Medical Center

Recruiting

Church-based Intervention to Improve Physical Function in African Americans

Physical Function | Multiple Chronic Conditions

United States
Children's Hospital Medical Center, Cincinnati
Patient-Centered Outcomes Research Institute

Enrolling by invitation

Garnering Effective Telehealth 2 Help Optimize Multidisciplinary Team Engagement (GET2HOME)

Children With Complex Chronic Conditions

United States
Parker Research Institute
VIA University College; University of Southern Denmark

Completed

A Better Everyday Life Among Persons With Chronic Conditions (ABLE)

Chronic Conditions, Multiple

Denmark
University of Washington
Johns Hopkins University; National Institute of Diabetes and Digestive and... and other collaborators

Recruiting

Kidney Precision Medicine Project (KPMP)

Chronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditions

United States
PharmaEssentia

Recruiting

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Chronic Hepatitis B Infection | Chronic Hepatitis D Infection

Taiwan
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Minimal Residual Disease | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Far Eastern Memorial Hospital

Active, not recruiting

The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques

Metabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1

Taiwan
Ascentage Pharma Group Inc.

Not yet recruiting

A Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients With CML (POLARIS-2)

Chronic Myeloid Leukemia | CML | CML, Chronic Phase

United States
Siriraj Hospital

Recruiting

The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia Patients (BCR-ABL1)

Chronic Myelogenous Leukemia

Thailand
Chiesi Farmaceutici S.p.A.

Recruiting

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PILLAR)

Chronic Obstructive Pulmonary Disease

Bulgaria, United States, Argentina, Austria, Bosnia and Herzegovina, Chile, Croatia, Czechia, Estonia, Germany, Greece, Hungary, Israel, Latvia, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian Federation and more
Karaganda Medical University

Completed

Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD (COPD)

Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease Severe

Kazakhstan
Chiesi Farmaceutici S.p.A.

Recruiting

A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) (PILASTER)

Chronic Obstructive Pulmonary Disease

Bulgaria, United States, Albania, Argentina, Australia, Austria, Bosnia and Herzegovina, Chile, China, Czechia, Georgia, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian... and more
University of North Carolina, Chapel Hill
Johns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI); University... and other collaborators

Active, not recruiting

Study of COPD Subgroups and Biomarkers (SPIROMICS)

Chronic Obstructive Pulmonary Disease | Emphysema | COPD | Chronic Bronchitis

United States
Bristol-Myers Squibb
PPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaborators

Completed

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib (DASCERN)

Chronic Phase Chronic Myeloid Leukemia

Italy, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
University of Copenhagen
Stine Kristensen; Gita Krüger Mørch; Rizwan Butt; Ditte Hansen

Not yet recruiting

a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients (RCTOIP)

Chronic Kidney Disease Requiring Chronic Dialysis

Denmark
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke... and other collaborators

Completed

Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation

Chronic Kidney Disease | Chronic Kidney Disease Requiring Chronic Dialysis

United States
Pavol Jozef Safarik University
Dialysis Services Fresenius Medical Care Slovakia; Private Health Institution...

Completed

Intradialytic Resistance Training in Haemodialysis Patients (IRTHEP)

Chronic Kidney Disease Requiring Chronic Dialysis

Slovakia
McGill University Health Centre/Research Institute...

Completed

Intradialytic Pedalling Exercise and Vascular Hemodynamic Parameters Among Prevalent Hemodialysis Population

Chronic Kidney Disease Requiring Chronic Dialysis
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Performance Comparison of Revaclear With Larger Dialyzer (Revacom HD)

Renal Failure Chronic Requiring Hemodialysis

Austria
Baxter Healthcare Corporation
University of Louisville; Gambro Renal Products, Inc.

Completed

Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis

Chronic Kidney Disease | Chronic Renal Disease

United States
Gilead Sciences

Recruiting

Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Chronic Hepatitis D Infection

United States
Hamad Medical Corporation

Terminated

Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia (DANIN)

Chronic Myeloid Leukemia - Chronic Phase

Qatar
Arbeitsgemeinschaft medikamentoese Tumortherapie
AOP Orphan Pharmaceuticals AG

Completed

Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

Chronic Phase Chronic Myeloid Leukemia

Austria
University of Michigan Rogel Cancer Center

Terminated

Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

Chronic Myeloid Leukemia

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States
Novartis Pharmaceuticals

Completed

Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate

Leukemia

United States
Ariad Pharmaceuticals

Terminated

A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia (OPTIC-2L)

Chronic Phase Chronic Myeloid Leukemia

Belgium
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation

Completed

Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients

Chronic Phase Chronic Myeloid Leukemia

United States

Clinical Trials on Chronic Paraplegia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations